Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression.
Reyes
J
J
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh Transplant Institute, Pennsylvania.
Tzakis
A G
AG
Bonet
H
H
Green
M
M
Yunis
E
E
Nalesnik
M
M
Nour
B
B
Kocoshis
S
S
Abu-Elmagd
K
K
Todo
S
S
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D015994:Incidence; D007223:Infant; D007422:Intestines / Q000276:immunology / Q000473:pathology / Q000637:transplantation*; D008232:Lymphoproliferative Disorders / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects*; D013997:Time Factors
D016559:Tacrolimus